Showing results (71-80 of 836) with videos related to
Sort By:
Pageof 84
The Journal of Clinical Investigation|October 2, 2014
The contributory role of gut microbiota in cardiovascular diseaseW H Wilson Tang, Stanley L HazenExpert Opinion on Emerging Drugs|March 16, 2007
Emerging drugs for acute and chronic heart failure: current and future developmentsStephen Y Chen, W H Wilson TangThe Journal of Cardiovascular Aging|July 27, 2022
Gut microbiota in sarcopenia and heart failureChia-Feng Liu, W H Wilson TangHeart Failure Reviews|February 18, 2014
Atrial fibrillation as manifestation and consequence of underlying cardiomyopathies: from common conditions to genetic diseasesAdam Mohmand-Borkowski, W H Wilson TangCurrent Treatment Options in Cardiovascular Medicine|March 23, 2015
Contribution of environmental toxins in the pathogenesis of idiopathic cardiomyopathiesAntonio L Perez, W H Wilson TangCurrent Heart Failure Reports|January 6, 2011
Aldosterone-receptor antagonists in heart failure: insights after EMPHASIS-HFMiriam S Jacob, W H Wilson TangHeart (British Cardiac Society)|March 4, 2017
Amyloid heart disease: genetics translated into disease-modifying therapyBrett W Sperry, W H Wilson TangF1000Research|October 23, 2018
Protecting the heart in cancer therapyJ Emanuel Finet, W H Wilson TangThe American Heart Hospital Journal|March 24, 2005
Trends and treatment of heart failure developing after acute myocardial infarctionW H Wilson Tang, Gary S FrancisRecent Patents on Cardiovascular Drug Discovery|February 1, 2008
Vasopressin receptor antagonists in heart failureRobert E Hobbs, W H Wilson TangPageof 84